<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>9976988</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">35511160</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">9976988</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.1093/brain/awac150</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="publisher-id">awac150</article-id></all-ids><extracted-table><table-id>awac150-T1</table-id><table-label>Table 1</table-label><table-caption>Demographic and clinical characteristics</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="awac150-T1"><label>Table 1</label><caption><p>Demographic and clinical characteristics</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col valign="top" align="left" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">CTR (<italic toggle="yes">n</italic> = 52)</th><th align="center" rowspan="1" colspan="1">FLE (<italic toggle="yes">n</italic> = 56)</th><th align="center" rowspan="1" colspan="1">TLE (<italic toggle="yes">n</italic> = 64)</th><th align="center" rowspan="1" colspan="1">Test statistic (<italic toggle="yes">F</italic>, <italic toggle="yes">H or</italic> χ²)</th><th align="center" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value</th><th align="center" rowspan="1" colspan="1"><italic toggle="yes">Post hoc</italic> tests (Bonferroni-corrected)</th></tr></thead><tbody><tr><td rowspan="3" colspan="1">Age at scan, years, mean (SD)</td><td rowspan="3" colspan="1">34.1 (10.4)</td><td rowspan="3" colspan="1">33.4 (10.2)</td><td rowspan="3" colspan="1">39.2 (10.7)</td><td rowspan="3" colspan="1">5.6</td><td rowspan="3" colspan="1"><bold>0</bold>.<bold>005</bold></td><td rowspan="1" colspan="1">FLE/CTR: 1.00</td></tr><tr><td rowspan="1" colspan="1">FLE/TLE: <bold>0.008</bold></td></tr><tr><td rowspan="1" colspan="1">TLE/CTR: 0.029</td></tr><tr><td rowspan="1" colspan="1">Sex, female/male</td><td rowspan="1" colspan="1">30/22</td><td rowspan="1" colspan="1">29/27</td><td rowspan="1" colspan="1">44/20</td><td rowspan="1" colspan="1">3.7</td><td rowspan="1" colspan="1">0.15</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Handedness, L/R/A</td><td rowspan="1" colspan="1">6/46/0</td><td rowspan="1" colspan="1">5/49/2</td><td rowspan="1" colspan="1">10/52/2</td><td rowspan="1" colspan="1">3.0</td><td rowspan="1" colspan="1">0.59</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Side of seizure focus, L/R</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">30/26</td><td rowspan="1" colspan="1">34/30</td><td rowspan="1" colspan="1">0.0</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Aetiological categories, non-lesional/FCD/DNET/glial tumour/other<sup><xref rid="awac150-tblfn2" ref-type="table-fn">a</xref></sup>/HS</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">29/13/6/3/5/0</td><td rowspan="1" colspan="1">0/0<sup><xref rid="awac150-tblfn3" ref-type="table-fn">b</xref></sup>/0<sup><xref rid="awac150-tblfn3" ref-type="table-fn">b</xref></sup>/0/0/64</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Frontal lesion site, (pre)motor-SMA/lateral/mesial/orbital/other</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">12/9/1/3/2</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Age of epilepsy onset, years, median (IQR)</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">10.0 (6.0)</td><td rowspan="1" colspan="1">13.0 (11.8)</td><td rowspan="1" colspan="1">2.3</td><td rowspan="1" colspan="1">0.13</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Duration of epilepsy, years, median (IQR)</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">21.0 (15.0)</td><td rowspan="1" colspan="1">22.5 (24.3)</td><td rowspan="1" colspan="1">0.6</td><td rowspan="1" colspan="1">0.44</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Seizure frequency, monthly, log, mean (SD)</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">1.15 (0.81)</td><td rowspan="1" colspan="1">0.87 (0.55)</td><td rowspan="1" colspan="1">4.8</td><td rowspan="1" colspan="1"><bold>0</bold>.<bold>03</bold></td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">FBTCS, yes/no</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">31/23</td><td rowspan="1" colspan="1">20/44</td><td rowspan="1" colspan="1">8.2</td><td rowspan="1" colspan="1"><bold>0</bold>.<bold>005</bold></td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">FBTCS frequency, monthly, log, mean (SD)</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">−0.07 (0.86)</td><td rowspan="1" colspan="1">−0.32 (0.62)</td><td rowspan="1" colspan="1">1.2</td><td rowspan="1" colspan="1">0.27</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Time since last seizure, days, median (IQR)</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">1.0 (6.8)</td><td rowspan="1" colspan="1">5.0 (8.0)</td><td rowspan="1" colspan="1">2.8</td><td rowspan="1" colspan="1"><bold>0</bold>.<bold>005</bold></td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">AEDs, median (IQR)</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">3.0 (1.0)</td><td rowspan="1" colspan="1">2.5 (1.0)</td><td rowspan="1" colspan="1">1.3</td><td rowspan="1" colspan="1">0.25</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Topiramate/Zonisamide, yes/no</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">15/41</td><td rowspan="1" colspan="1">12/52</td><td rowspan="1" colspan="1">1.1</td><td rowspan="1" colspan="1">0.38</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Levetiracetam, yes/no</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">29/27</td><td rowspan="1" colspan="1">41/23</td><td rowspan="1" colspan="1">1.9</td><td rowspan="1" colspan="1">0.20</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Task-fMRI data availability, verbal fluency/verb generation/verbal WM/visual WM, no. of participants</td><td rowspan="1" colspan="1">52/51/51/52</td><td rowspan="1" colspan="1">56/56/53/50</td><td rowspan="1" colspan="1">63/63/63/62</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="3" colspan="1">Frontal language LI, verbal fluency fMRI, median (IQR)</td><td rowspan="3" colspan="1">0.79 (0.32)</td><td rowspan="3" colspan="1">0.67 (0.56)</td><td rowspan="3" colspan="1">0.76 (0.29)</td><td rowspan="3" colspan="1">10.5</td><td rowspan="3" colspan="1"><bold>0</bold>.<bold>005</bold></td><td rowspan="1" colspan="1">FLE/CTR: <bold>0.004</bold></td></tr><tr><td rowspan="1" colspan="1">FLE/TLE: 0.094</td></tr><tr><td rowspan="1" colspan="1">TLE/CTR: 0.744</td></tr><tr><td rowspan="3" colspan="1">Frontal language LI, verb generation fMRI, median (IQR)</td><td rowspan="3" colspan="1">0.81 (0.23)</td><td rowspan="3" colspan="1">0.65 (1.15)</td><td rowspan="3" colspan="1">0.70 (0.41)</td><td rowspan="3" colspan="1">9.1</td><td rowspan="3" colspan="1"><bold>0</bold>.<bold>01</bold></td><td rowspan="1" colspan="1">FLE/CTR: <bold>0.019</bold></td></tr><tr><td rowspan="1" colspan="1">FLE/TLE: 1.00</td></tr><tr><td rowspan="1" colspan="1">TLE/CTR: <bold>0.030</bold></td></tr></tbody></table><table-wrap-foot><fn id="awac150-tblfn1"><p>A = ambidextrous; CTR = healthy controls; HS = hippocampal sclerosis; IQR = interquartile range; L = left; LI = laterality index; R = right; WM = working memory. In the <italic toggle="yes">P-</italic>value and <italic toggle="yes">Post hoc</italic> tests columns, statistically significant group comparisons (<italic toggle="yes">P</italic> &lt; 0.05) are highlighted in bold font. Categorical variables were compared with Fisher’s exact test (χ² statistic is reported). Continuous normally/non-normally distributed demographic variables are reported as mean (SD)/median (IQR) and were compared via ANOVA (<italic toggle="yes">F</italic> statistic)/Kruskal–Wallis test (<italic toggle="yes">H</italic> statistic), respectively. Pairwise deletion was applied in case of missing data. Age at onset (and, consequently, epilepsy duration) could not be accurately documented for five people with FLE. For details about computation of language LIs, see <xref rid="sup1" ref-type="supplementary-material">Supplementary material</xref>.</p></fn><fn id="awac150-tblfn2"><p>One patient with possible periventricular nodular heterotopia, and five with miscellaneous MRI abnormalities (described in the ‘Materials and methods’ section).</p></fn><fn id="awac150-tblfn3"><p>Hippocampal sclerosis coexisted with DNET in three patients (one left/two right) and with a possible FCD in one patient (right).</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic and clinical characteristics</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><colgroup><col valign="top" align="left"/><col valign="top" align="center"/><col valign="top" align="center"/><col valign="top" align="center"/><col valign="top" align="center"/><col valign="top" align="center"/><col valign="top" align="center"/></colgroup><thead><tr><th align="center"/><th align="center">CTR (n = 52)</th><th align="center">FLE (n = 56)</th><th align="center">TLE (n = 64)</th><th align="center">Test statistic (F, H or χ²)</th><th align="center">P-value</th><th align="center">Post hoc tests (Bonferroni-corrected)</th></tr></thead><tbody><tr><td rowspan="3">Age at scan, years, mean (SD)</td><td rowspan="3">34.1 (10.4)</td><td rowspan="3">33.4 (10.2)</td><td rowspan="3">39.2 (10.7)</td><td rowspan="3">5.6</td><td rowspan="3">0.005</td><td>FLE/CTR: 1.00</td></tr><tr><td>FLE/TLE: 0.008</td></tr><tr><td>TLE/CTR: 0.029</td></tr><tr><td>Sex, female/male</td><td>30/22</td><td>29/27</td><td>44/20</td><td>3.7</td><td>0.15</td><td/></tr><tr><td>Handedness, L/R/A</td><td>6/46/0</td><td>5/49/2</td><td>10/52/2</td><td>3.0</td><td>0.59</td><td/></tr><tr><td>Side of seizure focus, L/R</td><td>–</td><td>30/26</td><td>34/30</td><td>0.0</td><td>1.00</td><td/></tr><tr><td>Aetiological categories, non-lesional/FCD/DNET/glial tumour/other???/HS</td><td>–</td><td>29/13/6/3/5/0</td><td>0/0???/0???/0/0/64</td><td>–</td><td>–</td><td/></tr><tr><td>Frontal lesion site, (pre)motor-SMA/lateral/mesial/orbital/other</td><td>–</td><td>12/9/1/3/2</td><td>–</td><td>–</td><td>–</td><td/></tr><tr><td>Age of epilepsy onset, years, median (IQR)</td><td>–</td><td>10.0 (6.0)</td><td>13.0 (11.8)</td><td>2.3</td><td>0.13</td><td/></tr><tr><td>Duration of epilepsy, years, median (IQR)</td><td>–</td><td>21.0 (15.0)</td><td>22.5 (24.3)</td><td>0.6</td><td>0.44</td><td/></tr><tr><td>Seizure frequency, monthly, log, mean (SD)</td><td>–</td><td>1.15 (0.81)</td><td>0.87 (0.55)</td><td>4.8</td><td>0.03</td><td/></tr><tr><td>FBTCS, yes/no</td><td>–</td><td>31/23</td><td>20/44</td><td>8.2</td><td>0.005</td><td/></tr><tr><td>FBTCS frequency, monthly, log, mean (SD)</td><td>–</td><td>−0.07 (0.86)</td><td>−0.32 (0.62)</td><td>1.2</td><td>0.27</td><td/></tr><tr><td>Time since last seizure, days, median (IQR)</td><td>–</td><td>1.0 (6.8)</td><td>5.0 (8.0)</td><td>2.8</td><td>0.005</td><td/></tr><tr><td>AEDs, median (IQR)</td><td>–</td><td>3.0 (1.0)</td><td>2.5 (1.0)</td><td>1.3</td><td>0.25</td><td/></tr><tr><td>Topiramate/Zonisamide, yes/no</td><td>–</td><td>15/41</td><td>12/52</td><td>1.1</td><td>0.38</td><td/></tr><tr><td>Levetiracetam, yes/no</td><td>–</td><td>29/27</td><td>41/23</td><td>1.9</td><td>0.20</td><td/></tr><tr><td>Task-fMRI data availability, verbal fluency/verb generation/verbal WM/visual WM, no. of participants</td><td>52/51/51/52</td><td>56/56/53/50</td><td>63/63/63/62</td><td>–</td><td>–</td><td/></tr><tr><td rowspan="3">Frontal language LI, verbal fluency fMRI, median (IQR)</td><td rowspan="3">0.79 (0.32)</td><td rowspan="3">0.67 (0.56)</td><td rowspan="3">0.76 (0.29)</td><td rowspan="3">10.5</td><td rowspan="3">0.005</td><td>FLE/CTR: 0.004</td></tr><tr><td>FLE/TLE: 0.094</td></tr><tr><td>TLE/CTR: 0.744</td></tr><tr><td rowspan="3">Frontal language LI, verb generation fMRI, median (IQR)</td><td rowspan="3">0.81 (0.23)</td><td rowspan="3">0.65 (1.15)</td><td rowspan="3">0.70 (0.41)</td><td rowspan="3">9.1</td><td rowspan="3">0.01</td><td>FLE/CTR: 0.019</td></tr><tr><td>FLE/TLE: 1.00</td></tr><tr><td>TLE/CTR: 0.030</td></tr></tbody></table></div>A = ambidextrous; CTR = healthy controls; HS = hippocampal sclerosis; IQR = interquartile range; L = left; LI = laterality index; R = right; WM = working memory. In the P-value and Post hoc tests columns, statistically significant group comparisons (P &lt; 0.05) are highlighted in bold font. Categorical variables were compared with Fisher’s exact test (χ² statistic is reported). Continuous normally/non-normally distributed demographic variables are reported as mean (SD)/median (IQR) and were compared via ANOVA (F statistic)/Kruskal–Wallis test (H statistic), respectively. Pairwise deletion was applied in case of missing data. Age at onset (and, consequently, epilepsy duration) could not be accurately documented for five people with FLE. For details about computation of language LIs, see ???.One patient with possible periventricular nodular heterotopia, and five with miscellaneous MRI abnormalities (described in the ‘Materials and methods’ section).Hippocampal sclerosis coexisted with DNET in three patients (one left/two right) and with a possible FCD in one patient (right).</transformed-table></extracted-table></extracted-tables-set>